When myosin light chain kinase (myosin light chain kinase, MLCK) was inhibited in hepatocellular carcinoma cells, both p38 MAPK phosphorylation and E-calmodulin expression were elevated, and cell migration was significantly inhibited [30]. The gene discussed is MYLK; the disease is hepatocellular carcinoma.